These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23565800)

  • 21. Ligand-guided receptor optimization.
    Katritch V; Rueda M; Abagyan R
    Methods Mol Biol; 2012; 857():189-205. PubMed ID: 22323222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knowledge-Based Strategy to Improve Ligand Pose Prediction Accuracy for Lead Optimization.
    Gao C; Thorsteinson N; Watson I; Wang J; Vieth M
    J Chem Inf Model; 2015 Jul; 55(7):1460-8. PubMed ID: 26090547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Confidence Protein-Ligand Complex Modeling by NMR-Guided Docking Enables Early Hit Optimization.
    Proudfoot A; Bussiere DE; Lingel A
    J Am Chem Soc; 2017 Dec; 139(49):17824-17833. PubMed ID: 29190085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An NMR-based scoring function improves the accuracy of binding pose predictions by docking by two orders of magnitude.
    Orts J; Bartoschek S; Griesinger C; Monecke P; Carlomagno T
    J Biomol NMR; 2012 Jan; 52(1):23-30. PubMed ID: 22167466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMR in natural products: understanding conformation, configuration and receptor interactions.
    Carlomagno T
    Nat Prod Rep; 2012 May; 29(5):536-54. PubMed ID: 22456471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maximum common binding modes (MCBM): consensus docking scoring using multiple ligand information and interaction fingerprints.
    Renner S; Derksen S; Radestock S; Mörchen F
    J Chem Inf Model; 2008 Feb; 48(2):319-32. PubMed ID: 18211051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QM/MM as a tool in fragment based drug discovery. A cross-docking, rescoring study of kinase inhibitors.
    Gleeson MP; Gleeson D
    J Chem Inf Model; 2009 Jun; 49(6):1437-48. PubMed ID: 19459698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein-ligand docking accounting for receptor side chain and global flexibility in normal modes: evaluation on kinase inhibitor cross docking.
    May A; Zacharias M
    J Med Chem; 2008 Jun; 51(12):3499-506. PubMed ID: 18517186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MM-GB/SA rescoring of docking poses in structure-based lead optimization.
    Guimarães CR; Cardozo M
    J Chem Inf Model; 2008 May; 48(5):958-70. PubMed ID: 18422307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application and limitations of X-ray crystallographic data in structure-based ligand and drug design.
    Davis AM; Teague SJ; Kleywegt GJ
    Angew Chem Int Ed Engl; 2003 Jun; 42(24):2718-36. PubMed ID: 12820253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ph4Dock: pharmacophore-based protein-ligand docking.
    Goto J; Kataoka R; Hirayama N
    J Med Chem; 2004 Dec; 47(27):6804-11. PubMed ID: 15615529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flexible protein-flexible ligand docking with disrupted velocity simulated annealing.
    Huang Z; Wong CF; Wheeler RA
    Proteins; 2008 Apr; 71(1):440-54. PubMed ID: 17957770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of protein-ligand docking with simulated chemical shift perturbations.
    Ten Brink T; Aguirre C; Exner TE; Krimm I
    J Chem Inf Model; 2015 Feb; 55(2):275-83. PubMed ID: 25357133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDS: flexible ligand and receptor docking with a continuum solvent model and soft-core energy function.
    Taylor RD; Jewsbury PJ; Essex JW
    J Comput Chem; 2003 Oct; 24(13):1637-56. PubMed ID: 12926007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling and selection of flexible proteins for structure-based drug design: backbone and side chain movements in p38 MAPK.
    Subramanian J; Sharma S; B-Rao C
    ChemMedChem; 2008 Feb; 3(2):336-44. PubMed ID: 18081134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.
    Perola E; Walters WP; Charifson PS
    Proteins; 2004 Aug; 56(2):235-49. PubMed ID: 15211508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Latest developments in molecular docking: 2010-2011 in review.
    Yuriev E; Ramsland PA
    J Mol Recognit; 2013 May; 26(5):215-39. PubMed ID: 23526775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B.
    Collins I; Caldwell J; Fonseca T; Donald A; Bavetsias V; Hunter LJ; Garrett MD; Rowlands MG; Aherne GW; Davies TG; Berdini V; Woodhead SJ; Davis D; Seavers LC; Wyatt PG; Workman P; McDonald E
    Bioorg Med Chem; 2006 Feb; 14(4):1255-73. PubMed ID: 16249095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining in silico tools and NMR data to validate protein-ligand structural models: application to matrix metalloproteinases.
    Bertini I; Fragai M; Giachetti A; Luchinat C; Maletta M; Parigi G; Yeo KJ
    J Med Chem; 2005 Dec; 48(24):7544-59. PubMed ID: 16302796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.